Related references
Note: Only part of the references are listed.Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
Jurrien G. P. Reijnders et al.
JOURNAL OF HEPATOLOGY (2011)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Kinetics of Hepatitis B Surface Antigen Decline During 3 Years of Telbivudine Treatment in Hepatitis B e Antigen-Positive Patients
Karsten Wursthorn et al.
HEPATOLOGY (2010)
Is response to antiviral treatment influenced by hepatitis B virus genotype?
Sara Raimondi et al.
JOURNAL OF HEPATOLOGY (2010)
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
R. G. Gish et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Early HBeAg Loss During Peginterferon α-2b Therapy Predicts HBsAg Loss: Results of a Long-Term Follow-Up Study in Chronic Hepatitis B Patients
Erik H. C. J. Buster et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Yun-Fan Liaw et al.
GASTROENTEROLOGY (2009)
Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
Rami Moucari et al.
HEPATOLOGY (2009)
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine
Mariko Kobayashi et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance
Jinlin Hou et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
Fuminaka Sugauchi et al.
HEPATOLOGY RESEARCH (2006)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
Karsten Wursthorn et al.
HEPATOLOGY (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Flares in chronic hepatitis B patients induced by the host or the virus?: Relation to treatment response during Peg-interferon α-2b therapy
HJ Flink et al.
GUT (2005)
Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan
Y Suzuki et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA
F Zoulim
JOURNAL OF HEPATOLOGY (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop
Y Suzuki et al.
INTERVIROLOGY (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study
N Akuta et al.
JOURNAL OF HEPATOLOGY (2003)
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
SJ Pocock et al.
LANCET (2002)
Serum alanine amino transferase flares during interferon treatment of chronic hepatitis B: Is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
S Nair et al.
HEPATOLOGY (2001)
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B
YF Liaw et al.
HEPATOLOGY (2000)
Share Paper
